Manni Mohyuddin: Suggested approach to 1st relapse of myeloma post – ASCO24

Manni Mohyuddin shared on X/Twitter:

“Suggested approach to 1st relapse of myeloma post ASCO24

Its suddenly more complicated-and bispecifics will change this too.

Bela based triplets >> Dara/Bort/Dex, but CD38+Carfil/Dex still great.

Safety of cilta-cel remains in Q, hard to broadly recommend for now.”

Source: Manni Mohyuddin/X

Dr. Manni Mohyuddin is an Assistant Professor at the Huntsman Cancer Institute, University of Utah, specializing in oncology. He is mainly interested in myeloma, supportive care, end-of-life management, and implementing cost-effective, evidence-based treatment strategies.